Business Standard

Biocon standalone net profit declines 43.72% in the March 2022 quarter

Image

Capital Market

Sales rise 5.31% to Rs 517.70 crore

Net profit of Biocon declined 43.72% to Rs 38.10 crore in the quarter ended March 2022 as against Rs 67.70 crore during the previous quarter ended March 2021. Sales rose 5.31% to Rs 517.70 crore in the quarter ended March 2022 as against Rs 491.60 crore during the previous quarter ended March 2021.

For the full year,net profit declined 69.30% to Rs 86.10 crore in the year ended March 2022 as against Rs 280.50 crore during the previous year ended March 2021. Sales declined 14.31% to Rs 1738.20 crore in the year ended March 2022 as against Rs 2028.40 crore during the previous year ended March 2021.

 
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales517.70491.60 5 1738.202028.40 -14 OPM %5.1213.61 -3.5215.41 - PBDT87.30111.70 -22 247.90462.30 -46 PBT59.2086.30 -31 139.70358.80 -61 NP38.1067.70 -44 86.10280.50 -69

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 29 2022 | 7:59 AM IST

Explore News